XML 17 R5.htm IDEA: XBRL DOCUMENT v3.21.2
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME - USD ($)
$ in Thousands
 3 Months Ended 6 Months Ended
Jun. 30, 2021
Jun. 30, 2020
Jun. 30, 2021
Jun. 30, 2020
Statement of Comprehensive Income [Abstract]        
Net income $ 202,606 $ 148,996 $ 406,895 $ 260,852
Other comprehensive income (loss), net of tax:        
Foreign currency translation adjustments 12,087 7,006 (7,246) (15,200)
Unrealized gain (loss) on Euro-denominated notes, net of tax expense (benefit) of $(313) and $837 in 2021 and $(532) and $(202) in 2020 (994) (1,689) 2,654 (642)
Unrealized gain (loss) on investments, net of tax expense (benefit) of $2 and $48 in 2021 and $(93) and $(181) in 2020 7 (295) 154 (574)
Unrealized gain (loss) on derivative instruments:        
Unrealized gain (loss) on foreign currency exchange contracts, net of tax expense (benefit) of $(594) and $655 in 2021 and $(805) and $1,247 in 2020 (1,224) (3,888) 3,191 5,538
Unrealized gain (loss) on cross currency swaps, net of tax expense (benefit) of $(349) and $694 in 2021 and $(283) and $586 in 2020 (1,106) (1,447) 2,202 2,602
Reclassification adjustment for loss (gain) included in net income, net of tax benefit (expense) of $340 and $876 in 2021 and $(339) and $(579) in 2020 2,375 (1,473) 4,269 (2,574)
Unrealized gain (loss) on derivative instruments 45 (6,808) 9,662 5,566
Other comprehensive gain (loss), net of tax 11,145 (1,786) 5,224 (10,850)
Comprehensive income 213,751 147,210 412,119 250,002
Less: Comprehensive income attributable to noncontrolling interest 24 56 56 85
Comprehensive income attributable to IDEXX Laboratories, Inc. $ 213,727 $ 147,154 $ 412,063 $ 249,917